Display options
Cite
Thomas LG. Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry. Pharmacoeconomics. 1994;6:67-70doi: 10.2165/00019053-199400061-00016.
Thomas, L. G. (1994). Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry. PharmacoEconomics, 667-70. https://doi.org/10.2165/00019053-199400061-00016
Thomas, L G. "Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry." PharmacoEconomics vol. 6 (1994): 67-70. doi: https://doi.org/10.2165/00019053-199400061-00016
Thomas LG. Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry. Pharmacoeconomics. 1994;6:67-70. doi: 10.2165/00019053-199400061-00016. PMID: 10155588.
Copy Download .nbib Format: NLM
Share it on

Pharmacoeconomics. 1994;6:67-70. doi: 10.2165/00019053-199400061-00016.

Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry.

PharmacoEconomics

L G Thomas

Affiliations

  1. School of Business, Emory University, Atlanta, Georgia, USA.

PMID: 10155588 DOI: 10.2165/00019053-199400061-00016

Abstract

This paper examines the nature of Japanese government regulation of pharmaceutical prices, and the impact of that regulation on the competitive performance of the Japanese industry. Possible implications for the reintroduction of pharmaceutical price controls in the US are also considered.

Cited by

MeSH terms

Publication Types

LinkOut - more resources